LncRNA PKMYT1AR promotes cancer stem cell maintenance in non-small cell lung cancer via activating Wnt signaling pathway.
LncRNA PKMYT1AR promotes cancer stem cell maintenance in non-small cell lung cancer via activating Wnt signaling pathway.
复制标题
LncRNA PKMYT1AR通过激活Wnt信号通路促进非小细胞肺癌干细胞维持
DOI:
10.1186/s12943-021-01469-6
复制
发表时间:
2021-12-02
期刊:
影响因子:
37.3
通讯作者:
Chen Y
中科院分区:
文献类型:
--
作者:
He Y;Jiang X;Duan L;Xiong Q;Yuan Y;Liu P;Jiang L;Shen Q;Zhao S;Yang C;Chen Y
BackgroundNon-small cell lung cancer (NSCLC) is the most common type of human lung cancers, which has diverse pathological features. Although many signaling pathways and therapeutic targets have been defined to play important roles in NSCLC, limiting efficacies have been achieved.MethodsBioinformatics methods were used to identify differential long non-coding RNA expression in NSCLC. Real-time RT-PCR experiments were used to examine the expression pattern of lncRNA PKMYT1AR, miR-485-5p. Both in vitro and in vivo functional assays were performed to investigate the functional role of PKMYT1AR/miR-485-5p/PKMYT1 axis on regulating cell proliferation, migration and tumor growth. Dual luciferase reporter assay, fluorescent in situ hybridization (FISH), immunoblot, co-immunoprecipitation experiments were used to verify the molecular mechanism.ResultHere, we identify a human-specific long non-coding RNA (lncRNA, ENST00000595422), termed PKMYT1AR (PKMYT1 associated lncRNA), that is induced in NSCLC by Yin Yang 1 (YY1) factor, especially in cancerous cell lines (H358, H1975, H1299, H1650, A549 and SPC-A1) compared to that in normal human bronchial epithelium cell line (BEAS-2B). We show that PKMYT1AR high expression correlates with worse clinical outcome, and knockdown of PKMYT1AR inhibits tumor cell proliferation, migration and xenograft tumor formation abilities. Bioinformatic analysis and a luciferase assay demonstrate that PKMYT1AR directly interacts with miR-485-5p to attenuate the inhibitory role on its downstream oncogenic factor PKMYT1 (the protein kinase, membrane-associated tyrosine/threonine 1) in NSCLC. Furthermore, we uncover that miR-485-5p is downregulated in both cancerous cell lines and peripheral blood serum isolated from NSCLC patients compared to reciprocal control groups. Consistently, forced expression of miR-485-5p inhibits the proliferation and migration abilities of tumor cells. Moreover, we provide evidence showing that PKMYT1AR targeting antisense oligonucleotide (ASO) dramatically inhibit tumor growth in vivo. Mechanistic study shows that PKMYT1AR/ miR-485-5p /PKMYT1 axis promotes cancer stem cells (CSCs) maintenance in NSCLC via inhibiting β-TrCP1 mediated ubiquitin degradation of β-catenin proteins, which in turn causes enhanced tumorigenesis.ConclusionsOur findings reveal the critical role of PKMYT1AR/miR-485-5p /PKMYT1 axis during NSCLC progression, which could be used as novel therapeutic targets in the future.
登录
查看更多内容
影响因子:
50.3
作者:
Carrot-Zhang, Jian;Chambwe, Nyasha;Beroukhim, Rameen
通讯作者:
Beroukhim, Rameen
影响因子:
14.9
作者:
Li JH;Liu S;Zhou H;Qu LH;Yang JH
通讯作者:
Yang JH
影响因子:
37.3
作者:
Jen J;Tang YA;Lu YH;Lin CC;Lai WW;Wang YC
通讯作者:
Wang YC
影响因子:
8
作者:
Chow, J. P. H.;Poon, R. Y. C.
通讯作者:
Poon, R. Y. C.
影响因子:
6.8
作者:
Price C;Chen J
通讯作者:
Chen J